Filing Details
- Accession Number:
- 0001264908-11-000001
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-03-01 15:43:58
- Reporting Period:
- 2011-02-28
- Filing Date:
- 2011-03-01
- Accepted Time:
- 2011-03-01 15:43:58
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1003124 | Pharmaceutical Product Development Inc | PPDI | Services-Commercial Physical & Biological Research (8731) | 561640186 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1264908 | L David Grange | 929 North Front Street Wilmington NC 28401 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2011-02-28 | 34,501 | $20.45 | 95,546 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2011-02-28 | 34,501 | $26.00 | 61,045 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options (to buy) | Disposition | 2011-02-28 | 34,501 | $0.00 | 34,501 | $20.45 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 69,005 | 2011-02-25 | 2020-02-25 | No | 4 | M | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options (to buy) | $21.98 | 2010-07-01 | 2019-07-01 | 155,259 | 155,259 | Direct |
| Common Stock | Stock Options (to buy) | $26.64 | 2011-06-17 | 2020-06-17 | 50,000 | 50,000 | Direct |
| Common Stock | Stock Options (to buy) | $41.32 | 2008-05-21 | 2018-05-20 | 6,485 | 6,485 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2019-07-01 | 155,259 | 155,259 | Direct |
| 2020-06-17 | 50,000 | 50,000 | Direct |
| 2018-05-20 | 6,485 | 6,485 | Direct |
Footnotes
- 50,000 shares of restricted stock were granted upon the Reporting Person's acceptance of employment as Chief Executive Officer. These shares vest in four equal increments on 7/1/10, 7/1/11, 7/1/12 and 7/1/13.
- The options vest in three equal installments on 6/17/11, 6/17/12 and 6/17/13.
- The options vest in three equal installments on 2/25/11, 2/25/12 and 2/25/13.
- The options vest in four equal installments of 50,000 on 7/1/10, 7/1/11, 7/1/12 and 7/1/13.
Billionaire Hedge Funds
